Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot crossover study of Gaviscon chewable tablets versus Losec MUPS versus placebo for post-meal heartburn relief
2010-019414-24Phase 2Completed
- Sponsor
- Reckitt
- Start
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial in gastroesophageal reflux disease (GERD) comparing Gaviscon chewable tablets, Losec MUPS and Placebo tablets (3 arms). Primary endpoint: Area under the Heartburn Relief curve from 0 to 60 minutes post-dose. Started Jun 2010; status: completed.
02
Drugs
magnesium trisilicateomeprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on 2010-019414-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019414-24.